Fincab 60/5 mg (Pimasartan Potassium, Esamlodipine)

Adult dose

The recommended dosage of this medication is 1 tablet once a day, taken with water regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). In patients whose blood pressure is not adequately controlled with 30 mg of Pimasartan monotherapy, 30/2.5 mg should be administered. For patients not adequately controlled with 60 mg of Pimasartan monotherapy, 60/2.5 mg should be administered.

Child dose

The safety and efficacy for pediatric and adolescent patients under 18 years of age have not been established.

This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy. Therefore, if pregnancy is confirmed, usage should be discontinued immediately. Individuals who are allergic to the main ingredients of this medication or similar substances, pregnant or breastfeeding women, patients undergoing dialysis, patients with moderate to severe liver impairment, patients with bile duct obstruction, and those with specific kidney dysfunction or diabetes should not take this medication. Patients with low blood volume or sodium deficiency, impaired renal function, renovascular hypertension, certain heart valve diseases, severe hypotension, elderly patients, and those allergic to specific pigments should use this medication carefully. Possible side effects when taking this medication may include dizziness, headache, edema, urinary disturbances, insomnia, flushing, and serious adverse reactions have been reported rarely. Patients with hypotension or electrolyte imbalance should correct their condition before taking this medication and carefully monitor symptoms during treatment, and take appropriate measures if hypotension occurs. This medication may increase blood potassium levels, so patients with heart failure or renal disease should undergo regular blood tests. Precaution is needed for certain kidney disease patients due to the risk of worsening renal function. There may be interactions when taken with other antihypertensives or specific medications, so it's essential to inform your healthcare provider about any ongoing medication. Pregnant or breastfeeding women should avoid using this medication, and breastfeeding should be stopped if taking this medication. It is recommended not to use this medication in children under the age of 18, as safety and efficacy have not been established. Elderly patients may be more sensitive to this medication, requiring careful monitoring. Patients with moderate to severe liver impairment should not take this medication. Overdose may lead to symptoms such as hypotension and cardiac arrhythmias, and immediate medical attention should be sought. This medicine should be kept out of the reach of children, and transferring it to another container may compromise its quality.

Serious side effects

• Hives
• severe swelling (edema)
• difficulty breathing
• severe allergic reactions
• jaundice
• liver abnormalities
• severe neurological symptoms
• severe edema or urinary abnormalities
• acute renal failure
• confusion

Mild side effects

• Dizziness
• orthostatic dizziness
• headache
• facial edema
• peripheral edema
• urinary disturbances
• insomnia
• flushing
• dyspepsia
• vomiting

This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it is recommended to store the medication at room temperature between 1°C and 30°C to maintain its efficacy and safety.

Appearance

Orange, rounded square film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle